Back to all articles
Commercial Directors
Medical Devices
Sales Coaching
Sales Performance
Team Development

How Commercial Directors in Medical Devices Can Scale Coaching Without Scaling Headcount

Emma Walsh
8 min read
Share

A Commercial Director at a mid-size orthopaedic device company recently described her challenge in terms that will be familiar to anyone in the same role.

"I have 75 reps across four territories. I have six regional managers. Each manager is responsible for coaching 12-13 reps while also managing their own key accounts, attending internal meetings, and handling escalations. In practice, each rep gets one observed field visit every 6-8 weeks. That's not coaching. That's spot-checking."

The mathematics of coaching in medical device sales simply do not work. The development needs are significant. The conversations reps face are complex. But the time and headcount available for coaching are structurally insufficient.

This is not a management failure. It is a scaling problem.

The coaching gap in medical device sales

Medical device selling is among the most demanding commercial roles in any industry. Reps navigate conversations with surgeons who expect clinical peers, procurement directors who challenge every pound, hospital administrators who demand ROI proof, and committee members who compare against multiple competitors.

Each of these conversations requires specific skills. A rep who excels at surgeon engagement may struggle with procurement objections. A rep who handles pricing pressure well may lack clinical credibility. The skill development needs are individual, varied, and ongoing.

Traditional coaching addresses this through manager observation and feedback. The manager rides along, observes the rep in action, and provides targeted coaching based on what they see. This model works beautifully when it happens. The problem is frequency.

Gallup's research on coaching effectiveness in sales organisations shows a clear correlation between coaching frequency and performance outcomes. Reps who receive weekly coaching significantly outperform those who receive monthly coaching. Those who receive monthly coaching significantly outperform those coached quarterly.

In medical device sales, most reps receive meaningful coaching far less than monthly. The structural constraints, manager span of control, geographic dispersion, travel requirements, and competing priorities, make high-frequency coaching mathematically impossible without adding headcount.

Why adding headcount is not the answer

The obvious solution is more managers. Split the territories. Reduce span of control. Give each manager fewer reps to coach.

For most Commercial Directors, this is not a viable option. Adding a layer of management increases cost without directly generating revenue. It introduces coordination complexity. It requires finding experienced managers, and experienced medical device sales managers are scarce and expensive.

Even when organisations do invest in additional management layers, the improvement is often disappointing. The new managers may be excellent sellers promoted into coaching roles without sufficient coaching skill themselves. The classic problem of promoting top performers into management roles is particularly acute in medical devices, where clinical expertise and selling skill are not the same as coaching ability.

Adding one manager might improve the coaching ratio from 1:13 to 1:10. That marginal improvement will not produce the step-change in team performance that Commercial Directors need to hit aggressive revenue targets.

The insight: separating practice from coaching

The insight that changes the equation is simple but often missed. Coaching and practice are different activities that have been conflated.

Coaching is a human skill: asking the right questions, providing contextual feedback, building confidence, and developing the individual's self-awareness. It requires emotional intelligence, domain expertise, and a relationship of trust.

Practice is a repetition activity: attempting the conversation, receiving feedback, adjusting, and repeating. It requires a realistic conversation partner, immediate feedback, and sufficient volume to build automaticity.

In the traditional model, the manager does both. They provide the practice opportunity (by observing field calls or facilitating role play) and the coaching (by debriefing and providing developmental feedback). Because the two activities are bundled, practice can only happen at the frequency of coaching, which is structurally limited.

Separating these activities changes the economics. If practice can happen independently of the manager, every rep can get high-volume practice without consuming manager time. The manager's limited coaching hours are then freed for higher-value activities: strategic account planning, complex deal support, career development, and targeted intervention where human judgement is essential.

What scalable practice looks like

AI-powered conversation practice gives every rep unlimited access to realistic buyer conversations. The AI adapts to their responses, maintains persona consistency, and provides structured feedback after each conversation.

For a Commercial Director, this means several things practically.

Volume without cost. A rep can practise 10 procurement objection conversations in an hour. In the field, they might encounter 10 such conversations across two months. The compression of practice volume is orders of magnitude.

Consistency without dependence. Every rep gets the same quality practice regardless of their manager's coaching skill. The rep in Manchester gets the same developmental experience as the rep in London, regardless of who their regional manager is.

Readiness visibility without ride-alongs. The Commercial Director can see exactly who is practising, what they are practising, and how their skills are developing. This visibility previously required physical observation, which at scale was impossible.

Targeted intervention with data. When practice data reveals that a specific rep struggles with value articulation, or that the entire team has a gap in handling consolidation objections, the Commercial Director can deploy targeted interventions. The manager's limited coaching time goes where it will have the most impact.

Restructuring the coaching operating model

Commercial Directors who successfully scale development through practice typically restructure their coaching model around three tiers.

Tier 1: Self-directed practice (daily/weekly, no manager time required). Reps access AI practice scenarios relevant to their current challenges, upcoming meetings, and identified skill gaps. They build fluency through repetition and receive immediate AI feedback. This replaces the need for managers to facilitate basic skill-building.

Tier 2: Data-informed manager coaching (monthly, high-impact). Managers use practice data to identify which reps need their attention and on which specific skills. Monthly coaching conversations are targeted and evidence-based rather than general and observational. The manager arrives knowing exactly what the rep struggles with.

Tier 3: Strategic Commercial Director oversight (quarterly, directional). The Commercial Director reviews team-level capability data to identify systemic gaps, inform training investments, and connect skill development to commercial outcomes. They see patterns across territories and product lines that individual managers cannot see.

This model gives every rep high-frequency practice while using scarce manager and director time for activities that genuinely require human judgement.

The impact on revenue targets

For Commercial Directors, every performance lever ultimately connects to revenue. Practice at scale affects revenue through several mechanisms.

Faster ramp time means new reps contribute to quota sooner. If AI practice reduces ramp from 12 months to 8 months, that is four months of additional productive selling per new hire. For a team adding 10-15 new reps per year, the revenue impact is substantial.

Higher win rates come from better prepared reps. A rep who has practised the procurement negotiation 10 times is more likely to hold price and close the deal than one who is encountering that objection for the first time in the field.

Better product launch velocity results from conversational readiness. When a new device launches, the window for competitive advantage is narrow. Teams that can sell the new product effectively from day one capture share that slower teams never recover.

Reduced attrition is a less obvious but significant lever. Reps who feel supported and see themselves improving are more likely to stay. The cost of replacing a medical device rep, including recruitment, training, and lost territory coverage, typically exceeds a full year's salary.

Practical implementation for Commercial Directors

For Commercial Directors considering this approach, the implementation is straightforward.

Start with a specific capability gap. Do not try to boil the ocean. Identify the one or two conversation types where your team most needs improvement. Procurement objection handling. New surgeon engagement. Product launch messaging. Competitive displacement.

Deploy practice scenarios for that gap. Give your team immediate access to AI practice conversations that simulate those specific situations. Make it easy to access, low-friction to start, and relevant to what they face this week.

Measure behaviour change, not completion. Do not track how many reps completed the programme. Track how their capability improves across practice sessions. Look for specific improvements in how they handle the targeted skill area.

Connect to commercial outcomes over time. As practice data accumulates, correlate it with pipeline and revenue metrics. Which reps who practise most are also winning most? Which capability improvements correspond to better commercial results?

Build the business case with real data. After the initial deployment proves impact, use the data to justify broader investment. Show the leadership team that practice drives the metrics they care about: win rates, ramp time, and revenue per rep.

Platforms like TrainBox make this entire cycle practical for medical device commercial teams. From scenario design to deployment to measurement, the infrastructure exists to give every rep a scalable practice capability that has historically been impossible outside of one-to-one coaching.

The role of the Commercial Director does not change. You still own the number. You still need your team to perform. What changes is the mechanism. Instead of hoping that infrequent coaching conversations produce consistent behaviour change, you build a system where practice is continuous, feedback is immediate, and readiness is visible.


TrainBox helps medical device teams practise real conversations so they're ready when it matters.

Share this article